Image of Metformin and metabolic diseases: a focus on hepatic aspects

LITERATURE

Metformin and metabolic diseases: a focus on hepatic aspects


Metformin has been widely used as a first-line anti-diabetic medicine for the treatment of type 2
diabetes (T2D). As a drug that primarily targets the liver, metformin suppresses hepatic glucose production
(HGP), serving as the main mechanism by which metformin improves hyperglycemia of T2D. Biochemically,
metformin suppresses gluconeogenesis and stimulates glycolysis. Metformin also inhibits glycogenolysis, which is a
pathway that critically contributes to elevated HGP. While generating beneficial effects on hyperglycemia,
metformin also improves insulin resistance and corrects dyslipidemia in patients with T2D.


Availability

REQJ623-01Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Front. Med.
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous